KP
Kiora Pharmaceuticals Inc
🇺🇸XNAS.KPRXUnited StatesHealthcare
$2.60USDdown -0.05 (-1.89%)OpenEnd of day5:09 PM
Price$2.60-0.05 (-1.89%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US49721T5074
- CUSIP
- 49721T309
Company
- Employees
- 13
- Headquarters
- Encinitas, United States
- Website
- https://www.kiorapharma.com
- CEO
- Dr. Brian M. Strem Ph.D.
Market
- Shares outstanding
- 4.4M
- Market cap
- $11.5M
Key dates
- Next earnings
- Nov 6, 2026
Highlights
- Market cap
- $11.5M
- EPS LTM
- -$2.48calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.05calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0+100%up year on year
- Net income
- -$10.99M+8.31%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$8.61M-10.05%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.